COSMIC-313 and Advice to Community Oncologists Treating Advanced RCC

Dr Eric Jonasch reviews key efficacy outcomes from the COSMIC 313 trial, its clinical implications, and shares advice for community oncologists treating patients with advanced renal cell carcinoma.

Related Videos
Chandler H. Park, MD, an expert on renal cell carcinoma
Related Content